SHL Telemedicine introduces at-home biomarker blood test in Israel nextdigitalhealth.com

SHL Telemedicine, a pioneer in advanced personal telemedicine solutions, has announced the expansion of its services in Israel to include the capability of performing at-home Biomarker blood tests. This innovative diagnostic tool is designed to swiftly identify cardiac markers indicative of a heart attack, marking a significant breakthrough in emergency cardiac care. SHL Telemedicine’s at-home biomarker blood test is said to be the first in the world as well.